An investigation carried out in Seville evidence larelacion between the metabolic syndrome (MS) and cancer associated venous thromboembolic disease.
An investigation carried out in Seville evidence larelacion and cancer-associated venous thromboembolic disease and the metabolic syndrome (MS). the results of this research will be displayed at the thirty-ninth Congress Neumosur, the most important annual event on respiratory diseases from the South of Spain, which on this occasion is held in Badajoz from 16 to 18 March. -some previous studies had already suggested this link, but for the ETV of unknown cause (idiopathic), it had not studied so much for cancer-related (neoplastic) – in a sample of 113 patients with ETV, the prevalence of metabolic syndrome was 47%, no significant differences between both groups (45.5% in idiopathic) and 50% in neoplastic – it is also the first work which has assessed the metabolic syndrome as a predictive factor in the evolution of the ETV Seville, March of 2013.- specialists of the Hospital Virgen del RocÃo and the Institute of Biomedicine of Seville are present in Badajozin the 39 th Congress of Neumosur, the results of an investigation that has succeeded in establishing the relationship between metabolic syndrome (MS) and venous thromboembolism associated with cancer, show a high prevalence of Ms among patients with VTE associated with neoplasia. The metabolic syndrome (MS) is defined as a set of interrelated risk factors that identify people with an increased risk of cardiovascular disease. For his part, disease venous thromboembolic (VTE) includes deep...
Read More